ASCO 2020: AZ’s Tagrisso Sails Into Early-Stage NSCLC On ‘Momentous’ ADAURA Trial Data

83% Reduction In Disease Recurrence Or Death

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.